Galantamine for treatment-resistant schizophrenia [3]
Publication
, Journal Article
Allen, TB; McEvoy, JR
Published in: American Journal of Psychiatry
2002
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
American Journal of Psychiatry
DOI
Publication Date
2002
Volume
159
Issue
7
Start / End Page
1244 / 1245
Related Subject Headings
- Psychiatry
- 5203 Clinical and health psychology
- 3202 Clinical sciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Allen, T. B., & McEvoy, J. R. (2002). Galantamine for treatment-resistant schizophrenia [3]. American Journal of Psychiatry, 159(7), 1244–1245. https://doi.org/10.1176/appi.ajp.159.7.1244
Allen, T. B., and J. R. McEvoy. “Galantamine for treatment-resistant schizophrenia [3].” American Journal of Psychiatry 159, no. 7 (2002): 1244–45. https://doi.org/10.1176/appi.ajp.159.7.1244.
Allen TB, McEvoy JR. Galantamine for treatment-resistant schizophrenia [3]. American Journal of Psychiatry. 2002;159(7):1244–5.
Allen, T. B., and J. R. McEvoy. “Galantamine for treatment-resistant schizophrenia [3].” American Journal of Psychiatry, vol. 159, no. 7, 2002, pp. 1244–45. Scival, doi:10.1176/appi.ajp.159.7.1244.
Allen TB, McEvoy JR. Galantamine for treatment-resistant schizophrenia [3]. American Journal of Psychiatry. 2002;159(7):1244–1245.
Published In
American Journal of Psychiatry
DOI
Publication Date
2002
Volume
159
Issue
7
Start / End Page
1244 / 1245
Related Subject Headings
- Psychiatry
- 5203 Clinical and health psychology
- 3202 Clinical sciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences